Zoetis Inc
General ticker "ZTS" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $79.1B
Zoetis Inc follows the US Stock Market performance with the rate: 11.4%.
Estimated limits based on current volatility of 1.6%: low 162.20$, high 167.62$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-10-31, amount 0.43$ (Y1.05%)
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [152.07$, 217.92$]
- 2024-12-30 to 2025-12-30 estimated range: [178.36$, 248.82$]
Financial Metrics affecting the ZTS estimates:
- Positive: Non-GAAP EPS, $ of 5.32 > 2.29
- Positive: Operating profit margin, % of 35.92 > 19.51
- Positive: -3.48 < Investing cash flow per share, $ of -1.68
- Positive: Interest expense per share, $ of 0.52 <= 0.74
- Positive: Return on assets ratio (scaled to [-100,100]) of 14.07 > 7.10
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Negative: 0 < Inventory ratio change, % of 0.63
Short-term ZTS quotes
Long-term ZTS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7,776.00MM | $8,080.00MM | $8,544.00MM |
| Operating Expenses | $5,021.00MM | $5,192.00MM | $5,475.00MM |
| Operating Income | $2,755.00MM | $2,888.00MM | $3,069.00MM |
| Non-Operating Income | $-267.00MM | $-232.00MM | $-133.00MM |
| Interest Expense | $224.00MM | $221.00MM | $239.00MM |
| R&D Expense | $508.00MM | $539.00MM | $614.00MM |
| Income(Loss) | $2,488.00MM | $2,656.00MM | $2,936.00MM |
| Taxes | $454.00MM | $545.00MM | $596.00MM |
| Profit(Loss) | $2,034.00MM | $2,111.00MM | $2,340.00MM |
| Stockholders Equity | $4,543.00MM | $4,405.00MM | $4,997.00MM |
| Inventory | $1,923.00MM | $2,345.00MM | $2,564.00MM |
| Assets | $13,900.00MM | $14,925.00MM | $14,286.00MM |
| Operating Cash Flow | $2,213.00MM | $1,912.00MM | $2,353.00MM |
| Capital expenditure | $477.00MM | $586.00MM | $732.00MM |
| Investing Cash Flow | $-458.00MM | $-883.00MM | $-777.00MM |
| Financing Cash Flow | $-1,862.00MM | $-904.00MM | $-3,109.00MM |
| Earnings Per Share* | $4.29 | $4.51 | $5.08 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.